Deprecated: Creation of dynamic property PL_VBP_License::$version is deprecated in /var/www/healingmaps.imarkdev.com/wp-content/plugins/video-background-pro/license-page.php on line 92

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the listeo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170

Deprecated: Creation of dynamic property Vidbg_WPBakery::$vc_row_atts is deprecated in /var/www/healingmaps.imarkdev.com/wp-content/plugins/video-background-pro/inc/classes/vidbg_wpbakery.php on line 49
Ketamine Therapy - Page 16 of 23 - HealingMaps

From Crisis to Healing: Keta Medical Center’s Dr. Haviva Malina on Ketamine’s Potential

In this Q&A, we sit down with Dr. Haviva Malina, MD, a physician whose career bridges the critical fields of emergency medicine and mental health.

Read More

5 Simple Ways Ketamine Clinics Can Save Money

We are helping the ketamine practitioners solve increased overhead costs, complex insurance requirements, and supply chain issues.

Read More

Introducing The Healing Health Alliance – The First GPO for the Ketamine Industry

We are launching the Healing Health Alliance -- the ketamine industry's first GPO -- which will save clinics up to 20% on medical supplies.

Read More

2025 Ketamine Practitioner Intelligence Research Report

What are ketamine practitioner's biggest pain points? Our 2025 Ketamine Practitioner Intelligence Research Report breaks it down.

Read More

Ketamine Study Yields Surprising Findings That Could Change Depression Treatment

A new study from Stanford University has uncovered unexpected results about ketamine’s role in treating depression.

Read More

Spravato Nasal Spray to Be Subsidized in Australia for Treatment Resistant Depression

The Australian government has announced that Spravato will be added to the Pharmaceutical Benefits Scheme starting July 1.

Read More

J&J’s Spravato On Track to Become a $3.5B Drug By 2028

If the current trajectory holds, J&J's Spravato could reach up to 3.5 billion dollars in annual sales by 2028.

Read More

Ketamine Therapy Offers Hope for People with Treatment Resistant PTSD

A recent study highlights the potential of ketamine-assisted therapy to help people living with severe post-traumatic stress disorder.

Read More

The American Journal of Psychiatry Looks at Six Years of FDA-Approved Spravato

The American Journal of Psychiatry took a deep dive into what the last six years of FDA-approved nasal ketamine has looked like.

Read More

Anti-Aging Biohacker Bryan Johnson’s Ketamine Experiment

Super famous anti-aging biohacker Bryan Johnson shared an intriguing experiment with ketamine and brain activity.

Read More